Johnson & Johnson To Pay More Than $1.6 Billion To Resolve Healthcare Fraud Allegations

Monday, November 04, 2013

Tennessee will receive more than $12 million as part of a multistate and federal agreement resolving allegations pharmaceutical manufacturer Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., used deceptive marketing tactics. Specifically, the parties will pay $1.6 billion to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. 

J&J and Janssen will pay in excess of $1.2 billion to the states and the federal government to resolve four qui tam, or whistleblower, lawsuits filed in the U.S. District Court for the Eastern District of Pennsylvania under the provisions of the federal False Claims Act and similar state False Claims statutes. In addition, Janssen Pharmaceuticals, Inc. will plead guilty in federal court to a criminal misdemeanor charge of misbranding Risperdal in violation of the Food, Drug, and Cosmetic Act.  As part of the criminal plea, Janssen has agreed to pay an additional $400 million in criminal fines and forfeitures.

“We applaud the cooperative work of the states and federal government to stop drug companies from illegally marketing potentially dangerous drugs to the public,” Tennessee Attorney General Bob Cooper said.  “The public needs to be able to trust those responsible for their health and well-being, and that includes drug manufacturers and those who prescribe medications.” 

J & J and Janssen allegedly promoted, marketed and introduced Risperdal and Invega into interstate commerce for uses not approved by the Food and Drug Administration and for uses that were not medically indicated.  Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote a drug for an “off-label” or other use not identified in the FDA-approved product label.  The states contend that during the period Jan. 1, 1999 through Dec. 31, 2005, the companies promoted Risperdal for off-label uses and made false and misleading statements about the safety and efficacy of Risperdal.

The states additionally allege J&J and Janssen paid illegal kickbacks to health care professionals and long-term care pharmacy providers to induce them to promote or prescribe Risperdal to children, adolescents and the elderly when there was no FDA approval for Risperdal use in these patient populations. The states further contend that from Jan. 1, 2007 through Dec. 31, 2009, the companies promoted Invega for off-label uses and made false and misleading statements about the safety and efficacy of Invega.  The manufacturers’ alleged unlawful conduct caused false and/or fraudulent claims to be submitted to or caused purchases by government funded health care programs, including the state Medicaid programs. 

As part of the global resolution, the companies will enter into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will monitor the company’s future marketing practices.

A team from the National Association of Medicaid Fraud Control Units worked with the federal government on the investigation and conducted the settlement negotiations with the pharmaceutical manufacturers on behalf of the states.  Team members included representatives from the Offices of the Attorneys General for the states of New York, Massachusetts, Ohio and California.

Teenage Binge Drinking Rate In Tennessee Drops

Fewer teens and pre-teens in Tennessee are abusing alcohol, according to the findings of a five-year prevention effort. The emphasis was on changing community attitudes and behaviors and the risks of having five or more drinks on one occasion. Lead by the Tennessee Department of Mental Health and Substance Abuse Services, the state’s efforts achieved reductions in binge drinking ... (click for more)

Hutcheson Patient And Family Advisory Council To Hold Inaugural Meeting

Hutcheson will hold its first meeting of its Patient and Family Advisory Council  on Friday at noon at the hospital board room in Hutcheson Medical Center, 100 Gross Crescent Circle, Fort Oglethorpe. Attending the meeting will be PFAC Council Members, Hutcheson administration and board members.  Hutcheson is establishing a Patient and Family Advisory Council ... (click for more)

Youth Pleads Guilty In 2011 Club Fathom Shootings; Rakestraw Gets 3 Years In Prison

A teen who was 15 at the time nine people were shot outside Club Fathom downtown on Christmas Eve 2011 pleaded guilty to three counts of aggravated assault on Tuesday. Brandon Lebron Rakestraw, who is now 18, appeared before Criminal Court Judge Don Poole. He received a three-year prison term to serve. Rakestraw has been in jail for 10 months. Prosecutor Jason Demastus ... (click for more)

Erlanger Finishes Fiscal Year With $18 Million Profit

After a major loss the year before, Erlanger Health System finished the fiscal year with an $18 million profit, officials announced Monday night. It was well ahead of the $2 million gain that Erlanger had budgeted for, and far better than last year's $8 million loss. The profit was boosted by a first-time $19,587,000 from a Public Hospital Supplemental payment and essential ... (click for more)

ChattaData Is A Real Advance For The City

This past Tuesday, the city of Chattanooga's new performance management tool called ChattaData was unveiled. As the chairman of the City Council’s Budget & Finance Committee, I am excited to witness the city putting this important information online in a way that is accessible and transparent to all taxpayers. This approach shines light on how we as a city prioritize our ... (click for more)

Roy Exum: Apollos Hester’s Way

East View High was trailing at halftime by a pair of touchdowns in last Friday night’s game against unbeaten Vandegrift. But the players at the Georgetown, Texas, school each have a sticker on the back of their helmets that says “TPW” which is a constant reminder that “Tough People Win.” Then there is “attitude” and that is where running back Apollos Hester steps in. In what ... (click for more)